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Abstract Despite intensive research, it is still unclear
how an immediate and profound acceleration of exocytosis
is triggered by appropriate Ca2?-stimuli in presynaptic
terminals. This is due to the fact that the molecular
mechanisms of ‘‘docking’’ and ‘‘priming’’ reactions, which
set up secretory vesicles to fuse at millisecond time scale,
are extremely hard to study. Yet, driven by a fruitful
combination of in vitro and in vivo analyses, our mecha-
nistic understanding of Ca2?-triggered vesicle fusion has
certainly advanced in the past few years. In this review, we
aim to highlight recent progress and emerging views on the
molecular mechanisms, by which constitutively forming
SNAREpins are organized in functional, tightly regulated
units for synchronized release. In particular, we will focus
on the role of the small regulatory factor complexin whose
function in Ca2?-dependent exocytosis has been contro-
versially discussed for more than a decade. Special
emphasis will also be laid on the functional relationship of
complexin and synaptotagmin, as both proteins possibly act
as allies and/or antagonists to govern SNARE-mediated
exocytosis.
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The Ca2?-triggered exocytosis of neurotransmitters and
hormones is a tightly controlled process that has evolved
to meet temporal precision and speed of intercellular
communication. The core membrane fusion machinery is
constituted by a set of three highly conserved proteins
known as the SNAREs (N-ethylmaleimide-sensitive fac-
tor (NSF) attachment protein receptors) (for review see
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(sybII) associates with its cognate target SNAREs,
SNAP25 and syntaxin Ia (stxIa), on the plasma membrane
to form a coiled-coil ‘SNAREpin’, crosslinking both
membranes in the process. The formation of these mem-
brane-bridging trans-SNARE complexes is believed to
pull the lipid bilayers together and drive membrane
merger, which finally unites the interacting SNAREs in
cis-configuration on the fused membrane. SNARE pro-
teins are characterized by SNARE domains of *60 amino
acids, which form amphiphatic a-helices that can assem-
ble into a thermodynamically stable coiled-coil helix
bundle by favorable hydrophobic interactions of the inner
helix faces and a number of salt bridges on the outside [4,
5]. The free energy of SNARE complex formation is used
to overcome the strong repulsive force between both
membranes and bring them into close apposition [6].
Complex formation is thought to start at the N-termini of
SNARE proteins and progress in C-terminal direction in a
zipper-like fashion [7–9]. Complete assembly of the
SNARE complex is required to initiate efficient mem-
brane merger. Although the three SNARE proteins are
capable to induce slow fusion of liposomes in vitro, even
in the absence of additional factors [10], Ca2?-dependent
neurotransmitter release in vivo requires regulatory
components that confer speed and precision to the fusion
reaction [11]. Indeed, synapses in the mammalian brain
typically possess an extensive set of accessory and regu-
latory factors, like, e.g., SM proteins, Munc-13, CAPS
and synaptotagmin (syt) I, which seem to govern the
fusion process through sequential mechanistic stages by
regulating the assembly of the SNARE complex [12]. At
active zones, vesicles rest in a ‘‘primed’’ fusion-compe-
tent state prior to Ca2?-triggered fusion and, therefore,
SNARE assembly likely occurs in a discontinuous fashion
allowing for a metastable fusion intermediate. Though
alternative mechanistic scenarios have been discussed that
conceive SNARE assembly as a one-step process down-
stream of triggering [13], detailed structure–function
analyses (e.g., [9]) and biophysical assays probing the
assembly of single SNARE complexes with optical
tweezers delivered evidence for partially zippered inter-
mediates that might be transiently stabilized by the
repulsive forces between approaching membranes [14,
15]. However, one of the central open questions is how
assembly of SNARE complexes is paused in a coordinated
fashion to allow for fast synchronous release upon intra-
cellular Ca2?-elevations. From a mechanistic perspective,
the demanded metastable fusion intermediate might be
upheld by the action of a SNARE-interacting protein that
could serve as a transient fusion ‘‘clamp’’. However, the
existence and identity of the proclaimed ‘‘fusion clamp-
ing’’ factor have been debated for a long time.
Complexins: a family of SNARE-interacting
proteins
Complexins are likely the most controversially discussed
SNARE-interacting proteins involved in exocytosis. As
described in the course of this review, these small hydro-
philic proteins (15–20 kDa) are suspected to play a major
role in governing SNARE assembly during vesicle fusion.
Complexins were first identified due to their ability to bind
to and copurify with SNARE complexes [16, 17]. Today
four different complexin genes, cplxI–cplxIV, have been
described in mice, and corresponding orthologs also exist
in the human genome [18]. CplxI and cplxII isoforms in
mammalian species show an unusually high sequence
conservation, which underlines their importance for regu-
lated exocytosis. Indeed, the primary sequence of cplxII is
identical in mouse, rat, and human, while cplxI still shows
97 % sequence conservation among murine and human
orthologs [17, 18]. CplxI and cplxII are closely related
isoforms (86 % sequence identity), but show only limited
homology (24–28 % identity) to cplxIII and cplxIV, which
seem to form a second subfamily [18]. Interestingly, the
cplxI/II and cplxIII/IV subgroups mainly differ in their
C-terminal domain, which—in the case of cplxIII/IV—
carries an extension with a CAAX box motif for lipidation
at its C-terminal end [18]. All four complexin isoforms are
predominantly expressed in the central nervous system
[16–18], with cplxIV protein being largely restricted to
retinal ribbon synapses [18]. Complexin orthologs have
also been identified throughout the animal kingdom, which
suggest conserved function in regulated exocytosis. Inter-
estingly, compared to mammals, invertebrates like
Caenorhabditis elegans or Drosophila melanogaster
express only a smaller number of complexin isoforms,
which are sequence-wise closely related to the cplxI/II
subfamily but frequently also contain a C-terminal exten-
sion with a CAAX farnesylation motif like cplxIII/IV [18,
19]. Thus, complexin isoforms in higher vertebrates likely
evolved as functionally specialized versions of an ancestral
protein fulfilling a more general role.
Structural determinants of complexin
Complexins bind to the SNARE complex via an a-helical
motif that is located near the center of the protein [17, 20,
21]. Of all known isoforms, cplxIV exhibits the lowest
affinity for the SNARE complex, and thus efficient binding
of cplxIV to the membrane-anchored SNARE complex
critically depends on its correct localization at the plasma
membrane via a farnesyl-anchor [18]. As recently shown
by single molecule FRET experiments, cplxI not only binds
to the ternary SNARE complex but also interacts with a 1:1
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SNAP-25:stx1a complex [22], which might help to stabi-
lize the putative acceptor complex during early stages of
the fusion mechanism. Biochemical work by Jahn and
coworkers [20] suggested that cplxI/II’s binding efficiency
to the SNARE complex is determined by the identity of the
SNARE isoforms incorporated in the target complex.
Moreover, cplxI/II binding to the SNARE complex is very
fast and occurs with high affinity [23–25]. Deuterium
exchange experiments indicated that cplxI may stabilize
the SNARE complex conformation, especially the assem-
bled C-terminal region [21]. CplxII binding to the SNARE
complex may also intensify interactions between the
transmembrane regions of syntaxin and synaptobrevin [26].
Complexin:SNARE complex interactions have been
structurally resolved on atomic scale by X-ray crystallog-
raphy demonstrating that an a-helical complexin fragment
can attach in anti-parallel orientation to the groove formed
between syntaxin and synaptobrevin [21, 27]. Amino acids
48–70 (rat cplxI) form the so-called ‘central helix’ in the
middle of complexin, which constitutes the main binding
interface ([21, 27], Fig. 1). Mutations of amino acids
within this region diminish association of complexin with
the SNARE complex [28]. The N-terminal region directly
preceding the central helix (residues 29–47) seems to also
assume a helical conformation [20, 21, 27, 29], and the
motif has accordingly been named ‘accessory helix’
(Fig. 1). While this motif is not essential for SNARE
binding, N-terminally flanking residues (amino acids
41–47) seem to enhance SNARE binding of the central
helix [28]. Intriguingly, it has been postulated that helix
formation is nucleated in the accessory helix and subse-
quently propagates into the region of the central helix,
thereby potentially stabilizing the central helix and
increasing SNARE binding [29]. Flanking sequences on
the C-terminal side (residues 71–77) have also been sus-
pected to contribute to the stabilization of the central helix
[30]. Furthermore, in vitro phosphorylation of cplxI/II
(Ser115) by protein kinase CK2 has been shown to
strengthen complexin binding to ternary SNARE com-
plexes, suggesting that complexin:SNARE interactions
may be dynamically regulated by phosphorylation [31].
While complexin phosphorylation was demonstrated to
occur in vivo at two sites [31, 32], it is currently unclear
how phosphorylation of serine residues in the C-terminal
Fig. 1 Hypothetical view on complexin and its interaction with the
membrane-bridging SNARE complex. Vesicular SNARE (sybII,
blue) and target SNARE (syx, orange and SNAP-25, green) partially
assemble into trans-SNARE complex forming a high affinity binding
site for complexin (pink). The N-terminus of Complexin (NT, amino
acid 1–26) enhances fusion kinetics and fusogenicity [28, 45, 47, 48,
52, 63, 77, 78] while the accessory a-helix (AH, amino acid 27–47)
[29, 41, 48, 49, 65–68, 71] and the C-terminus (CT, amino acid
73–134) [19, 34, 44, 50, 52, 63, 72] clamp premature release. The
central helix (CH) of complexin binds with the SNARE complex [17,
20, 21, 27] which is prerequisite for all complexin actions [89]. The
major Ca2? sensor sytI (blue) interacts with SNAREs and membranes
upon Ca2?-binding to its C2 domains, but is displayed separately for
clarity of presentation
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domain could mechanistically influence the binding activ-
ity of the central helix.
Little is currently known about the structural features of
the very N-terminus (residues 1–25) and the C-terminal
domain (residues [83) of cplxI/II (Fig. 1). In the com-
plexin:SNARE complex, these regions remain susceptible
to proteolytic degradation and do not assume an a-helical
conformation [20]. This suggests that they do not engage in
tight interactions and may possibly stay unstructured.
Recent studies, however, indicated that the C-terminal
domain may contain an amphipathic helix that could bind
to phospholipids [33, 34] and thus might contribute to
localize complexin to synaptic vesicles. Such membrane-
anchoring function of the C-terminus of complexin would
be in line with the existence of prenylation sites in multiple
invertebrate complexin isoforms as well as cplxII/IV in
mammals. The sole D. melanogaster ortholog of complexin
was recently shown to possess two C-terminal splice
variants, of which one lacks the CAAX-box required for
prenylation [19]. In addition, the C-terminal domain of
complexin is subject to mRNA-editing further modifying
its sequence. These findings support the notion of a func-
tionally relevant specialization of the C-terminal domain in
different isoforms.
Function of complexin: to clamp or not to clamp?
Fast Ca2?-regulated exocytosis in secretory cells relies on a
functionally distinct pool of primed vesicles, which are
ready to fuse in response to a triggering Ca2?-stimulus. A
second larger pool of morphologically docked vesicles,
which is typically referred to as ‘depot pool’, serves as a
replenishing reservoir to compensate for vesicle loss by
exocytosis. For both types of vesicles, the dimensions of
intermembrane distances are compatible with membrane-
bridging interactions of SNARE proteins [35, 36] raising
the possibility that SNAREs assemble spontaneously [9,
10, 37] and cause premature loss of vesicles. The untimely
fusion of vesicles may contribute to so-called spontaneous
release, a form of untriggered vesicle fusion occurring
alongside evoked synaptic transmission at most chemical
synapses. While the specific role and the regulation of the
spontaneous release component are not fully understood
(for a recent review see [38]), it is clear that the majority of
docked vesicles is reluctant to fuse with the plasma
membrane in the absence of a proper stimulus. Hence, a
molecular mechanism must exist that effectively arrests
vesicles in the docked state allowing for an appropriate
stimulus-secretion coupling. Although other mechanisms
like restricted v-SNARE accessibility [39] might contribute
to the attenuation of premature release, complexin has been
proposed to play the principal role in ‘‘clamping’’ primed
vesicles.
Initial in vitro analyses using a liposome fusion assay
[40] or Hela cells that ectopically express ‘‘flipped’’
SNAREs on their cell surface [41] showed that complexin
can inhibit the SNARE-driven fusion machinery providing
direct evidence for a negative modulatory role in exocy-
tosis. In close correlation, genetic ablation of the relevant
complexin isoforms in the NMJs of invertebrates leads to a
strong increase in spontaneous release [34, 42–45]. In
contrast, knock-out and knock-down perturbations of
murine complexin resulted in opposing views about its role
in exocytosis. While genetic ablation of all complexin
isoforms expressed in brain either does not alter or even
reduces spontaneous release in autaptic hippocampal cul-
tures [28, 46] and brain slices [47], knockdown of cplxI/II
by RNA interference in mass cultured cortical neurons
increases spontaneous release [48–50]. More recent
experiments in mass cultured cortical neurons, designed to
deconstruct these phenotype differences, have shown that
genetic loss of cplxI/II unclamps spontaneous release [51].
Yet, in the same study, it has been reported that knock-
down of cplxI/II leads to complementary overexpression of
cplxIII and cplxIV. Since cplxIII expression in wild-type
cells enhances spontaneous release, it remains to be clari-
fied to what extent the unclamping phenotype is due to loss
of cplxI/II or off-target effects on cplxIII expression.
CplxII knock-out in chromaffin cells also demonstrated an
enhanced tonic release which is evident at elevated levels
of [Ca]i ([100 nM), but absent at low resting [Ca]i [52].
Given this observation, it is tempting to speculate that
variations in [Ca]i among the different preparations may
contribute to the deviating expression of the complexin null
phenotype in different preparations.
In the same line, several studies boosting complexin
action by either genetic overexpression or peptide sup-
plementation have provided evidence for the complexin
clamp function in neuronal and non-neuronal cells.
Expression of either cplxI or cplxII markedly suppresses
acetylcholine release from PC12 cells [53, 54] and also
strongly impairs hGH secretion from insulin secreting cell
lines [55]. Overexpression of cplxII in bovine [56] and
mouse chromaffin cells [52] also reduces catecholamine
secretion. Elevating local concentration of cplxI via a
cplxI-sybII fusion protein that selectively expresses at the
synapses of wild-type murine neurons impairs sponta-
neous synaptic vesicle fusion [57]. Moreover, acute
dialysis of zebrafish or mouse retinal bipolar cells with a
peptide derived from the conserved SNARE-binding
domain of cplxIII/IV increases spontaneous release, most
likely by competing with endogenous complexin for
SNARE binding [58, 59]. In acrosomal exocytosis, sup-
plementing permeabilized human sperm cells with cplxII
arrests exocytosis by clamping a loosely assembled trans-
SNARE complex [60].
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Based on these findings, it stands to reason that loss of
the complexin clamp action, particularly at elevated resting
[Ca]i, should lead to a depletion of the vesicle pools due to
unfettered exocytosis. Indeed, ultrastructural and high-
resolution imaging studies have shown that loss of com-
plexin results in a specific loss of membrane proximal
vesicles at C. elegans NMJ [43] and mouse chromaffin
cells [52]. Likewise, in absence of the complexin clamp
function, the depot pool of synaptic vesicles is also
depleted in the zebrafish and mouse retinal bipolar cells
[58, 59]. Conversely, autaptic hippocampal preparations
that do not show any increase in spontaneous activity in the
absence of cplxI and cplxII also reveal no change in vesicle
docking [46], a phenotype recently confirmed with state-of-
the art EM tomography of synaptic structures in hip-
pocampal brain slices [61]. In vitro liposome fusion assays
also display a decreased vesicle association that is
accompanied with enhanced spontaneous fusion in the
absence of complexin, emphasizing its clamp role [62, 63].
That said, it should be noted that complexin has been
shown to increase the on-rate of docking in liposome
fusion assays [64]. In contrast, loss of complexin in Dro-
sophila massively increases spontaneous release but neither
affects the number of total nor of docked SVs at the NMJ
[42, 45]. Given such excessive release in the absence of
complexin, one might speculate that mechanisms of the
insect NMJ have specially adapted to perpetuate the high
rate of vesicle exocytosis by speeding-up replenishment
reactions, masking potential vesicle depletion.
In conclusion, despite some remaining uncertainties, the
combined set of data from in vitro and in vivo studies
provides a model where complexin takes center stage in
clamping of premature vesicle release.
Mechanism of complexin’s clamp function
How does complexin clamp premature exocytosis? In vitro
analyses in Hela cells by Rothman and colleagues demar-
cated a region comprising amino acids 26–83 of cplxI as
the ‘minimal clamping domain’ of the protein. According
to their comprehensive mechanistic model, binding of the
complexin central helix (amino acids 48–70) to the
SNARE complex is a prerequisite for protein function, and
interaction of the complexin accessory a-helix (amino
acids 26–47) with the partly zippered SNARE complex
inhibits complete C-terminal assembly and membrane
fusion. The accessory helix is thought to compete with the
C-terminal portion of sybII for binding to its cognate
SNARE partners, hence providing an on–off switch by
alternative zippering [41, 65]. This mechanistic idea is
based on sequence similarities between the sybII
hydrophobic layers (layer position ?3, ?4 and ?7) and the
accessory helix of complexin (aligned in antiparallel
orientation) and was further tested by generation of com-
plexin mutants with enhanced sequence similarities (sybII-
mimetic, ‘superclamp’ mutation) or with sequence modi-
fications putatively decreasing this interaction (sybII-
divergent, ‘poor clamp’ mutation), which should facilitate
or hinder alternative zippering and thus modulate clamping
activity [65]. Whereas in vitro fusion studies using these
mutants delivered the expected results for clamping [65],
and binding assays showed corresponding small changes in
affinity to cis-SNARE complexes [49], in vivo studies
attempting to rescue the knock-down or knock-out phe-
notype revealed inconsistent results regarding the efficacy
of the mutant proteins to either superclamp (sybII-mimetic
mutation) or unclamp (sybII-divergent mutation) sponta-
neous release [49, 66, 67]. This illustrates some
mechanistic differences in the action of complexin in a
physiological context and in reductionist assays like cell–
cell fusion.
Ku¨mmel et al. recently addressed the structural config-
uration of the complexin-clamped prefusion SNAREpin by
studying a complex formed between the cplxI superclamp
mutant and a SNARE complex containing a C-terminally
truncated sybII variant, in which the accessory helix of
complexin can stably zipper into the complex without
interference of the competing region of sybII [68].
Intriguingly, the crystal structure of this complex suggested
a variation of the original model, wherein the central helix
of complexin binds to one SNARE complex, while the
adjacent accessory helix binds to a neighboring, second
SNARE complex [68, 69]. Based on these results, it has
been suggested that complexin may organize SNARE
complexes into a zigzag array that—when interposed
between vesicle and plasma membranes—hinders fusion.
Yet, the general hypothesis of insertion of the accessory a-
helix into the partially assembled SNARE complex (either
within or between complexes) is still highly controversial
due to conflicting results of ITC, FRET, and NMR analyses
addressing the underlying interactions between accessory
a-helix and SNARE bundle [67, 70]. It remains to be seen,
whether future studies can conclusively confirm this model.
Interestingly, Trimbuch et al. demonstrated a tenfold
decrease in the binding affinity of complexin’s central helix
to the SNARE complex upon truncation of the accessory a-
helix. This suggests an indirect effect of this motif on
complexin:SNARE interactions—a notion that agrees with
biochemical experiments showing decreased complexin
binding to the SNARE complex in absence of the accessory
a-helix [28]. Thus, it is possible that helicity of this region
is crucial for stabilizing complexin binding to SNAREs.
Based on the concentration of negatively charged amino
acids within the accessory a-helix, Trimbuch and col-
leagues [67] posited a model, wherein this protein region
inhibits release through enhancing electrostatic repulsion
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between vesicle and plasma membranes. Nevertheless, it
remains to be shown to what extent substitution or addition
of negatively charged amino acids alter the domain’s
helicity or the overall binding affinity for the SNARE
complex. Another molecular mechanism for the accessory
a-helix mediated clamp action has recently been proposed
by Bykhovskaia et al. [71]: using molecular dynamics
simulation, they concluded that the accessory a-helix
interacts directly with the v-SNARE sybII and thus arrests
the zippering of the last hydrophobic layers ?7 and ?8. In
this context, it is important to note that recent experiments
at the NMJ in C. elegans have shown an impaired com-
plexin inhibition, if helix propagation into the central helix
of complexin was disrupted [29]. Astonishingly, even
replacing the accessory a-helix with a non-native helical
sequence restored complexin function, suggesting that
neither primary protein sequence nor hydrophobicity or net
charge density of the accessory a-helix is required for
complexin inhibition. Yet, another mode of accessory a-
helix-mediated clamping action has been proposed for
murine central synapses wherein the accessory a-helix
putatively clamps an unidentified secondary Ca2?-sensor
whose activation would cause unfettered vesicle fusion in
absence of complexin [49].
Evidently, despite a large amount of experimental
efforts and various possible hypotheses, a satisfying con-
sensus regarding the mechanism by which the accessory a-
helix may clamp premature release has not been reached.
However, recent in vitro and in vivo experiments have
indicated that the C-terminus (amino acid 72–134) of
complexin can also exert a fusion clamping function
(Figs. 1, 2). Once considered to be functionally inert [28],
later experiments have shown that the C-terminal domain
actively clamps spontaneous liposome fusion as well as
synaptic vesicle exocytosis in both invertebrate [19, 34, 44,
72] and vertebrate neuronal preparations [50]. Furthermore,
experiments at the NMJ of C. elegans suggested that the
C-terminal domain of complexin tethers the protein via its
amphipathic helix to synaptic vesicles and thus concen-
trates the SNARE-binding region at the site of exocytosis
for efficient clamping [34]. However, experiments in
chromaffin cells counter the hypothesis of a simple tar-
geting role of the complexin C-terminus. They show that a
C-terminal truncation mutant (amino acids 1–72) actively
‘unclamps’ tonic secretion with expression in wild-type
cells [52]. These observations indicate that the mutant
competes with endogenous complexin for binding to pro-
ductive SNARE complexes, but has lost its ability to clamp
tonic secretion. Thus, the C-terminus actively suppresses
premature exocytosis, a property that may also rely on lipid
binding of this protein domain [33, 34, 50, 73]. Given that
two independent domains of complexin have been shown
to clamp spontaneous exocytosis, an attractive hypothesis
could be that the C-terminus actually folds back onto the
accessory a-helix, where it may promote protein–lipid and
protein–protein interactions with its amphipathic helix.
Such interactions may then stabilize the position of the
accessory a-helix on the SNARE complex. Undoubtedly,
more experiments addressing the mechanistic function of
the C-terminus are required for a true understanding of the
physiological clamp role of complexin.
Two in one sweep: facilitation of fusion
as a secondary function?
Knock-out and knock-down studies of complexin have
shown, as a common denominator, a prominent reduction
of evoked release, likely pointing to a direct facilitatory
role of complexin in synchronous neurotransmitter release
[28, 42–52, 57, 72, 74–79]. While compromised evoked
release may be due to depletion of primed vesicles by
premature spontaneous fusion [42, 45, 52, 58, 59], this
explanation cannot be generalized for all types of prepa-
rations. In model systems, in which spontaneous fusion rate
is unaffected by the abolishment of complexin, like, e.g., in
autaptic microisland cultures, diminished evoked release
has primarily been explained by a lowered release proba-
bility rather than a loss of primed vesicles [28, 46, 77].
In cultured neurons, the number of highly primed
synaptic vesicles, which rapidly undergo exocytosis upon a
Ca2?-stimulus and thus are thought to form a so-called
‘readily releasable pool’ (RRP), can be directly estimated
by application of hypertonic solution (500 mM sucrose). It
is believed that this method induces Ca2?-independent
release by subjecting synapses to an osmotic shock, pos-
sibly forcing vesicle fusion by mechanical stress.
Intriguingly, this technique did not reveal any reduction in
pool size for complexin-deficient hippocampal neurons in
autaptic microisland cultures [28, 46, 77], which largely
excludes vesicle depletion as the cause of compromised
synaptic transmission. Rather, Xue et al. [77] noticed a
slightly delayed release kinetic upon hypertonic challenge
in complexin-deficient synapses, which argues in favor of a
reduced fusogenicity of RRP vesicles in the absence of
complexin. In addition, a milder hypertonic shock
(250 mM sucrose) that does not fully deplete the RRP was
less efficient in inducing release in complexin-deficient
cells than in wild-type controls, which again indicates that
vesicles reside in a more fusion-reluctant state after abla-
tion of complexin [77]. Thus, deficits in evoked release
must be predominantly caused by the loss of a fusion-
facilitating effect of complexin in microisland cultures.
Interestingly, in the case of cultured cplxII-/- chromaffin
cells, in which premature release clearly diminishes the
built-up of primed vesicle pools, an additional reduction in
vesicular release rates and a significant delay in secretion
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onset have been observed in response to a step-wise
increase in [Ca]i [52]. These observations also agree with
the notion of a faltering fusion rate of primed vesicles in
the absence of complexin. Moreover, intriguing kinetic
changes of action potential evoked synaptic responses have
been demonstrated in several preparations: at fly and
murine NMJs, the genetic ablation of complexin results in
a desynchronization of release [45, 78, 80], which notice-
ably broadens the waveforms of evoked synaptic
responses, while the kinetics of synaptic miniature events
remains unchanged [45, 78]. These waveform changes
likely reflect a delayed and scattered release of individual
quanta, once again pointing to impeded fusion of primed
vesicles in synapses lacking complexin. Furthermore, sin-
gle-vesicle content mixing and liposome fusion assays
have provided convincing evidence for an enhanced Ca2?-
control of vesicle fusion in the presence of complexin [62,
81–83].
Thus, phenotypic cues from the vast majority of model
systems as well as in vitro analyses indicate a fusion-
Fig. 2 Hypothetical model of
complexin action on various
steps leading to vesicle
exocytosis. Spontaneous
SNARE zippering may lead to
premature fusion of docked or
primed vesicles in the course of
vesicle maturation. Complexin
with its accessory a-helix and
C-terminus prevents the
premature loss and thereby
increases the pool of primed
vesicles. Furthermore,
N-terminus of complexin
accelerates the kinetics of
primed vesicle fusion serving as
an ally of sytI in synchronizing
the release response. Therefore,
complexin promotes
synchronous vesicle fusion by
two distinct but synergistic
functions. The clamp action of
complexin C-terminus is
continued from ‘docking’ until
fusion ‘triggering’ where Ca2?-
bound sytI effectively
antagonizes the clamp leading
to rapid fusion pore expansion
Complexins: small but capable 4227
123
promoting action of complexin that either complements
concurrent complexin-mediated ‘‘clamping’’ of sponta-
neous fusion or even represents its chief function
depending on the particular model system.
Mechanistic insights into the fusion-promoting
function of complexin
For a true understanding of the role of complexin in
transmitter release, it is of utmost importance to elucidate
the exact mechanism underlying its facilitatory function
and to clarify whether facilitation is mechanistically inde-
pendent of clamping. To this end, it is helpful to review
available cues on the identity of complexin domains
involved in fusion-facilitation and to discuss their potential
mechanistic function. Employing the microisland culture
system, Xue et al. [28] found that the N-terminal region
(residues 1–26) is required to fully rescue evoked release in
cplxI-/- hippocampal neurons (Fig. 2). Interestingly,
mutation of residues 3–6 in cplxI eliminates the facilitating
effect on evoked release and impairs rescue in knock-out
neurons [77]. Based on structural considerations and bio-
physical experiments, Rosenmund and coworkers further
concluded that the involved N-terminal motif forms an
amphiphatic a-helical segment that binds to the C-terminal
end of the SNARE complex. Consequently, the observed
facilitating effect on evoked release may be explained by
the binding of this helical motif to the SNARE complex,
which could provide conformational support to the
assembling C-terminus during final stages of exocytosis. In
accord with this, Su¨dhof and colleagues [48] reported that a
truncated complexin variant (residues 27–134) is unable to
rescue evoked release after complexin knock-down but still
reconstituted normal spontaneous release. Due to related
phenotypic features of synaptobrevin linker mutants (sybII
W89A, W90A; but cf. [84]), this study proposed that the
complexin N-terminus is somehow assisting mechanical
force transfer onto membranes.
Noteworthy, a reduction of Ca2?-sensitivity of evoked
release has indeed been reported for complexin-deficient
neurons/endocrine cells in most preparations [28, 42, 46,
52, 85] (but see [49]), which rather supports the idea of a
mechanistic crosstalk between complexin and the Ca2?-
sensor synaptotagmin. Furthermore, some studies [45, 85]
have been able to observe a clear decrease in the Hill
coefficient for the Ca2?-cooperativity of release in com-
plexin-deficient cells. In the same line, expression of an
N-terminally truncated complexin variant (residues
28–134) in cplxII-/- chromaffin cells failed to re-establish
normal release rates, prolonged the secretory delay and
lowered the apparent Ca2?-affinity of secretion [52].
Exocytosis timing in chromaffin cells is largely determined
by the kinetics of Ca2?-binding to sytI [86]. Thus, the
mutant properties are characteristic for a decreased forward
rate of Ca2?-binding to the calcium sensor, hence, pointing
again to a role of the complexin N-terminus in modulating
sytI function (Fig. 2). Apart from kinetic changes, Dhara
et al. [52] reported that the N-terminally truncated com-
plexin variant could largely restore the overall amplitude of
Ca2?-triggered secretion in cplxII-deficient chromaffin
cells—seemingly in contrast to diminished evoked release
in neurons using similar mutants [28, 77]. However, the
data might be easily reconciled, when considering the
different durations of triggering Ca2?-stimuli used in these
preparations. Under conditions of sluggish stimulus secre-
tion coupling, chromaffin cells can still empty the entire
primed vesicle pool due to the long-lasting Ca2?-stimulus.
In neurons, however, slow stimulus-secretion coupling in
response to a rapid action potential evoked Ca2?-transient
would certainly cause a significant drop in the EPSC
amplitude, providing an attractive explanation for the
facilitatory phenotype of complexin’s N-terminus as well
as for kinetic changes of endplate responses at the NMJs of
complexin null mutants [45, 78]. Nevertheless, by com-
paring the phenotypes of single null mutants for complexin
and sytI, cplx-/-; sytI-/- double-deficiency and overex-
pression experiments, additive as well as interdependent
effects on release probability and exocytosis timing have
been observed in hippocampal neurons and the NMJ of
Drosophila [45, 77], leaving the exact mechanistic rela-
tionship between both proteins unclear.
Work by the Su¨dhof group has recently added another
intriguing facet to the putative facilitation mechanism by
proposing that complexin may also play a major role in
vesicle priming. This conclusion was reached mainly based
on cplxI/cplxII knock-down experiments in cortical mass
cultures [49–51]. In contrast to the release phenotype found
in microisland cultures (e.g., [28, 46]), knock-down or
knock-out of complexin in this type of neuronal prepara-
tion resulted in a substantial increase in spontaneous
release as well as a strongly reduced RRP size, as assayed
by hypertonic challenge. Intriguingly, Kaeser-Woo et al.
[50] demonstrated that a C-terminally truncated variant
(residues 1–86) can rescue evoked release but does neither
re-establish normal RRP size nor diminish elevated spon-
taneous release. While these results confirm that the
N-terminal domain is needed to sustain effective triggering,
they also suggest that the C-terminal domain is required for
efficient priming besides fusion clamping, consequently
attributing the overall facilitatory function of complexin to
independent actions of its two subdomains. This being said,
it is obviously troublesome that the phenotypic hallmarks
of the suspected complexin-dependent priming mechanism
are not equally well recognizable in all preparations—even
in so closely related culture types. Furthermore, recent
tomographic EM analyses were able to present some
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morphologic correlates for priming by studying SNARE-
deficient synapses in hippocampal slice culture, but were
unable to pinpoint a morphological priming defect in
complexin-deficient neurons [61]. Possibly, the priming
function of complexin is a non-essential feature that can be
compensated for by redundant mechanisms.
The idea of a facilitatory role of the N-terminal com-
plexin motif was lately also confirmed in trans-species
rescue experiments, in which a complexin chimera that
contains the N-terminus (residues 1–16) of D. melanoga-
ster and complementary sequences from the murine
ortholog (residues 17–134) was able to reconstitute normal
evoked release in murine complexin-deficient neurons [76].
However, the interpretation of such experiments is com-
plicated by the fact that fly and murine complexin
orthologs only possess limited functional interchangeabil-
ity. Indeed, full-length fly complexin is unable to substitute
for murine isoforms in rescue experiments and even sup-
presses synaptic release when expressed in mouse wild-
type neurons, while expression of murine cplxI-III in D.
melanogaster overly increases evoked synaptic responses
[72, 76]. Contrary to previous findings in mammals, Cho
et al. [66] found that expression of an N-terminally trun-
cated murine complexin variant (residues 51–134) was
fully able to rescue evoked transmission when expressed in
Drosophila null mutants, which challenges the view of the
fusion-promoting function of the N-terminal motif. Like-
wise, N-terminally truncated variants of the C. elegans
ortholog seem to completely rescue evoked release at body
wall-muscle NMJs [43, 44]. Moreover, the truncated
complexin variant (residues 16–143) tested by Hobson
et al. [43] not only increased the amplitude of evoked
EPSCs over the level of wild-type controls but also pro-
moted spontaneous release in the absence of extracellular
Ca2?—thus basically inverting the functional assignment
of domains established in mammals. It is currently not
clear, how to reconcile these contradicting findings in
vertebrates and invertebrates, since the N-terminal region
of D. melanogaster and C. elegans complexin shows some
sequence homology with murine cplxI/II and, thus, mech-
anistic similarities could be expected. One possible
explanation for this dilemma might be seen in the spe-
cialized functional properties of invertebrate
neuromuscular junctions that set them apart from central
synapses found in the central nervous system of verte-
brates. In particular, the C. elegans NMJ is unique with
respect to its high rates of spontaneous release (around
50 Hz). The physiological function of this high sponta-
neous synaptic activity is still unknown [87], but it might
be speculated that the release machinery at these synapses
evolutionary adapted to generate a specialized pattern of
synaptic activity. Following this idea, the mechanistic role
of complexin may also have changed during the
evolutionary adaptation of NMJ physiology, possibly by
tweaking its interaction with other factors governing
SNARE assembly.
To test the mechanistic function of specific complexin
domains under well-defined conditions in vitro, Lai et al.
[63] recently used a single liposome–liposome content
mixing assay and quantified liposome association, sponta-
neous fusion, amount of Ca2?-triggered fusion, and
synchronization of Ca2?-induced release. In good correla-
tion with in vivo analyses in vertebrates, they found that
Ca2?-induced fusion events in this model system occurred
less frequently and less synchronized in the presence of
complexin mutants lacking the N-terminus (amino acid
27–134), while spontaneously occurring release before
application of Ca2? was only changed in the absence of the
complexin C-terminus (amino acids 1–86). So, it can be
even recognized in a strongly reduced system only con-
taining the minimal fusion machinery that the complexin
N-terminus is critically involved in enhancing the fidelity
of liposome fusion.
In summary, there is increasing consensus that the major
fusion-promoting function of complexin in vertebrates is
mediated by its very N-terminus. This facilitatory action
seems mechanistically independent and even separable
from the clamping function of complexin, which is puta-
tively mediated by the accessory a-helix together with the
C-terminus (s. above). However, in invertebrates the
mechanistic role of complexin domains may deviate from
this pattern. Overall, these findings strengthen the view that
complexin conveys two synergistic functions to enhance
synchronous fusion of vesicles: (1) maintenance of a proper
primed vesicle pool by preventing its premature depletion
and (2) facilitation of fusion in response to the Ca2?-trigger.
Synaptotagmin: ally and antagonist?
In previous sections, we have discussed the janus-faced
actions of complexin during fusion—but have only mar-
ginally touched upon one mechanistic aspect that might
actually help to tie both functions together, namely the
interplay between complexin and the Ca2?-sensor sytI.
Indeed, it is immediately evident that the postulated com-
plexin-mediated ‘fusion clamp’ must be rapidly lifted when
fusion is triggered by above-threshold Ca2?-transients and
that the activation of the arrested state directly or indirectly
depends on an antagonistic action of sytI. In addition, the
facilitatory action of complexin seems to increase release
probability and calcium sensitivity in the majority of
preparations, making sytI again appear as a relevant
interaction partner for complexin (Fig. 2). Thus, the
mechanistic relationship between complexin and sytI is of
central importance for our understanding of complexin
function.
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While there is a notable consensus that sytI promotes
SNARE assembly and vesicle exocytosis upon presynaptic
Ca2?-elevations (e.g., [88, 89]), major aspects of its
molecular function have still remained enigmatic to date.
Structurally, sytI is a transmembrane protein that contains
two C2 homology domains, denoted C2A and C2B, within
its cytosolic part. SytI binds Ca2?, phospholipids, and the
SNARE complex via its C2 domains, though the specific
binding configuration is not yet clear (for a detailed review
see [90, 91]). Intriguingly, ablation of sytI leads to a
complex secretion phenotype featuring a conspicuous
desynchronization of release as well as an elevated rate of
spontaneous fusion in some model systems [92–98] but not
others [88, 99]. These observations are highly reminiscent
of the controversial phenotypes found with complexin
ablation. Given the inhibitory effects of sytI on sponta-
neous activity in several preparations, some studies have
entertained the idea that sytI itself could act as a major
component of the fusion clamp [100–102]. So, are sytI and
complexin potential allies in suppressing premature
release? While the idea of an sytI-mediated clamp mech-
anism has initially received support from in vitro studies
demonstrating an inhibitory effect of the isolated sytI
C2AB domain on liposome fusion in the absence of Ca2?
[103, 104], other studies indicated a general fusion-pro-
moting function of the full-length protein arguing against
genuine clamping by sytI in reduced model systems [62,
82, 83, 105–110]. Alternatively, the observed increase in
spontaneous release rate in the absence of sytI could be
explained by other syt isoforms improperly deputizing for
the role of calcium sensor [96, 98]. That said, it should be
noted that a GABAergic modulation of spontaneous glu-
tamatergic release rate was recently shown to influence the
expression of the sytI knock-out phenotype in some model
systems [111]. In any case, a potential mechanistic con-
nection between complexin and sytI should be most
obvious in double knock-out mutants that are deficient for
both sytI and complexin. Indeed, several groups have
recently generated and tested such double knock-out
mutants in mice and flies [45, 52, 77]. If both proteins
would ‘‘clamp’’ release cooperatively or independently at
the same mechanistic step, an unchanged or even exacer-
bated spontaneous release rate would be expected to occur
in double mutants. Surprisingly, however, Jorquera et al.
and Dhara et al. similarly reported that the phenotype of
cplx-/-; sytI-/- double mutants is virtually identical to the
one seen in sytI single knock-outs and also abolishes the
pronounced rate of spontaneous release typically observed
in cplx-/- flies and the increased tonic secretion in neu-
roendocrine cells. Thus, there clearly is a strong
mechanistic interdependence between the actions of both
proteins, but no mechanistically overlapping function in
fusion clamping. Indeed, it has been speculated that Ca2?-
independent binding of sytI to the SNARE complex may
increase the propensity of the complex to zipper up and
promote fusion. This inherent ‘‘leakiness’’ of the sensor-
system under resting conditions might be countered by the
action of complexin [45].
An antagonism between complexin and sytI also con-
stitutes the very backbone of popular concepts explaining
the relief of the complexin-mediated clamp of spontaneous
release. Mainly based on experimental cues from in vitro
fusion experiments [40, 41, 62, 65, 69, 112], it has been
proposed that a complexin-stabilized fusion intermediate
(see previous chapters) is activated by Ca2?-bound sytI
leading to subsequent C-terminal assembly of the SNARE
complex and membrane merger. Interestingly, biochemical
work by the groups of Rizo and Su¨dhof presented evidence
for a mutual exclusive binding of both proteins to the
SNARE complex and even demonstrated that either protein
can expel the other when presented at high enough con-
centrations [57, 113]. These findings led to the mechanistic
idea that sytI may antagonistically displace complexin
from the SNARE complex in a Ca2?-dependent fashion
and that this ‘complexin–synaptotagmin-switch’ may
underlay fusion triggering. Nevertheless, the postulated
competitive binding and displacement of complexin by sytI
have been highly controversial due to contradictory bio-
chemical results indicating a concurrent association of both
proteins with the SNARE complex [114]. Another study by
Tokumaru et al. [115] even postulated a C-terminal inter-
action of complexin with sytI and speculated that
complexin might be involved in recruiting sytI to the
SNARE complex—basically inverting the ‘complexin–sy-
naptotagmin-switch’-idea. Reconciling some of the
experimental controversies, Rizo’s group revealed in a
recent study that competitive effects between sytI and
complexin might be more subtle than previously assumed
(possibly restricted to subdomains) and depend on the
experimental conditions, especially whether or not the
SNARE complex is in a membrane-attached state [116].
Moreover, single-molecule FRET studies to elucidate the
sytI:SNARE binding configuration have led to a model
predicting largely unobstructed complexin binding to the
groove formed by syntaxin-1A and synaptobrevin even
when C2AB is simultaneously attached [117]. Direct evi-
dence for a persistent binding of complexin to the SNARE
complex has also come from total internal reflection fluo-
rescence microscopy experiments, in which GFP-tagged
complexin was shown to be recruited to prospective fusion
sites, remained at this position until after fusion, and was
eventually diminished by lateral spreading in the mem-
brane [118]—which strongly indicates that complexin
remains attached to the cis-complex after membrane mer-
ger. Thus, there is now accumulating evidence that both
proteins can bind simultaneously in a non-overlapping
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configuration to the SNARE complex, and that the antag-
onism of both proteins does not result from competition for
binding sites.
If Ca2?/sytI-mediated complexin displacement from the
SNARE complex represents an unlikely mechanism, how
else can the antagonistic function between sytI and com-
plexin be envisioned? Some intriguing observations have
lately been made in chromaffin cells, in which the cate-
cholamine release from single secretory granules can be
studied by amperometric recordings. Using this technique,
it could be shown that sytI loss delays the initial fusion
pore dilation and that this phenotype was reversed by
additional elimination of cplxII in sytI-/-; cplxII-/- dou-
ble knock-out cells [52]. These results suggest that the
prolonged fusion pore dilation seen in sytI-deficient cells is
actually caused by an action of cplxII, in accord with
earlier studies showing that complexin can impact fusion
pore behavior [56, 118]. This interpretation was further
supported by the finding that overexpression of cplxII in
wild-type cells could mimic the secretion phenotype of
sytI-/- cells, illustrating an antagonistic action of both
proteins in controlling early fusion pore dynamics [52].
Although cplxII deficiency was shown to have no effect on
fusion pore dilation at high Ca2? (20 lM) in this study, it
increasingly shortens the initial fusion pore duration with
lowering [Ca]i. This implies a push–pull mechanism,
wherein a sytI/Ca2?-mediated acceleration of fusion pore
dilation counteracts a cplxII ‘clamp’ action that counters
pore expansion. Intriguingly, the C-terminal domain of
complexin that is involved in suppressing premature fusion
was found to be also responsible for clamping the fusion
pore. Thus, sytI in its Ca2?-bound form overcomes cplxII-
mediated restraints on force transduction at the moment of
the Ca2?-rise to initiate formation and accelerate dilation
of fusion pore—putting both proteins in a truly antagonistic
relationship during the last steps of exocytosis. On the
molecular level, the functional antagonism between com-
plexin and sytI may be due to the induction of limited
conformational changes upon Ca2?-binding, as both factors
likely reside on the SNARE complex.
Though little is currently known about the conforma-
tional states involved in triggering, existing cues might at
least provide welcome primers for future research avenues:
Krishnakumar et al. [69] recently employed FRET exper-
iments to investigate conformational changes of the
complexin accessory helix during SNARE zippering and
reported that the accessory helix converges onto the
SNARE complex during assembly of the final layers.
Intriguingly, the authors conclude that switching to a
‘closed’ conformation is required for fusion triggering, as a
synaptobrevin variant that fails to undergo the conforma-
tional transition due to mutation of a group of residues (syb
D64A, D65A, D68A) responsible for binding the complexin
central helix also interferes with sytI-induced fusion in an
in vitro fusion assay. While the authors’ interpretation that
throwing the ‘switch’ lifts a fusion clamp on a neighboring
SNARE complex is highly controversial (see above),
changing the relative position of the accessory helix and
N-terminus might still be essential for switching the mode
of complexin action. Given that the very N-terminus is
fulfilling a facilitating function, such conformational
changes might place the domain close to the C-terminal
end of the SNARE complex where it promotes full
assembly of the SNARE proteins or regulates the binding
configuration of sytI. In both scenarios, it might exert a
fusion-promoting function wherein sytI and complexin act
as allies affecting vesicle fusogenicity and triggering. A
related view on complexin function was recently offered by
Erwin Neher, who suggested that it may act as an allosteric
adaptor for sytI [119]. Importantly, instead of postulating
autonomous ‘clamp’ and ‘triggering’ functions, this inter-
pretation explains the dual action of complexin as facets of
a simple allosteric mechanism, by which complexin mod-
ulates the Ca2?-dependency of release. Following this line
of argumentation, complexin loss may reduce the dynamic
range of the Ca2?-dependent secretion by invoking chan-
ges in the energy levels of the Ca2?-bound (increased
energy barrier) and its free states (decreased energy
barrier).
In summary, current evidence points to clearly antago-
nistic roles of complexin and sytI in clamping, with
Ca2?:sytI, possibly activating the arrested fusion interme-
diate without dislodging complexin (Fig. 2). The
antagonistic action of both proteins might even carry on to
very late stages of the fusion process, in which complexin
restricts fusion pore expansion, while sytI promotes it. In
facilitating release, sytI and complexin cooperate as part-
ners, but the interdependency of their actions needs further
investigation.
Concluding remarks
Almost 20 years after its identification as an SNARE-in-
teracting protein, complexin still remains an enigma. Even
though it has become clear by now that complexin serves a
dual function in vesicle fusion, namely clamping of pre-
mature release and facilitation of Ca2?-triggered vesicle
fusion, the underlying molecular mechanisms are still far
from understood. Evidently, complexin is small but cap-
able, because it seems to affect crucial players in the
exocytotic machinery with its few domains. Nevertheless,
based on our current knowledge, it needs to be stressed that
the seemingly counter-intuitive combination of fusion-in-
hibiting and fusion-promoting functions within one small
accessory factor has a tremendous synergistic impact on
the fidelity of Ca2?-triggered secretion.
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